Pharmaceutical preparations Sample Contracts

ARTICLE I AMENDMENTS
Polymedica Corp • September 13th, 2006 • Pharmaceutical preparations • New York
EXHIBIT B
Registration Rights Agreement • May 28th, 2008 • China Pharma Holdings, Inc. • Pharmaceutical preparations • New York
THE ELIGIBLE SUBSIDIARIES REFERRED TO HEREIN, AS BORROWERS
Credit Agreement • April 4th, 2006 • Allergan Inc • Pharmaceutical preparations • New York
ARTICLE 2 REPRESENTATIONS AND WARRANTIES OF SELLER
Stock Purchase Agreement • April 18th, 2005 • DU Deli • Pharmaceutical preparations • Nevada
INDENTURE BETWEEN
Indenture • September 6th, 2005 • Elite Pharmaceuticals Inc /De/ • Pharmaceutical preparations
SUBLEASE
Lease Agreement • July 25th, 2006 • Macrochem Corp • Pharmaceutical preparations • Massachusetts
AMONG
Purchase Agreement • August 5th, 2003 • Nbty Inc • Pharmaceutical preparations • New York
SERIES B COMMON STOCK PURCHASE WARRANT APTEVO THERAPEUTICS INC.
Aptevo Therapeutics Inc. • August 7th, 2023 • Pharmaceutical preparations

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time or times on or after August 4, 2023 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the eighteen (18) month anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Aptevo Therapeutics Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of common stock of the Company, par value $0.001 per share (the “Common Stock”). The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

by and among EPIMMUNE INC., HELENE PLOIX, as the Shareholder Representative, and the
Voting Agreement • March 18th, 2005 • Epimmune Inc • Pharmaceutical preparations • Delaware
VIRBAC CORPORATION FORM 10-Q SEPTEMBER 30, 2003
Stock Purchase Agreement • May 6th, 2005 • Virbac Corp • Pharmaceutical preparations • Delaware
RECITALS
Loan and Security Agreement • April 20th, 2006 • Quatrx Pharmaceuticals Co • Pharmaceutical preparations • California
PART II AMENDMENTS TO CREDIT AGREEMENT
Credit Agreement • April 1st, 2005 • Chattem Inc • Pharmaceutical preparations
WITH [NAME OF EMPLOYEE] (EMPLOYEE COPY)
Option Agreement • September 30th, 2005 • Predix Pharmaceuticals Holdings Inc • Pharmaceutical preparations • Delaware
and
Agreement and Plan of Merger • October 30th, 2007 • Bradley Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • August 7th, 2023 • Aptevo Therapeutics Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of August 1, 2023, between Aptevo Therapeutics Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

EXECUTION VERSION AGREEMENT AND PLAN OF MERGER
Agreement and Plan of Merger • July 18th, 2008 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • Delaware
CONNETICS CORPORATION, as Issuer
Supplemental Indenture • December 29th, 2006 • Connetics Corp • Pharmaceutical preparations • New York
ARTICLE I DEFINITIONS
Securities Purchase Agreement • September 16th, 2008 • Elite Pharmaceuticals Inc /De/ • Pharmaceutical preparations • New York
RECITALS
Loan Agreement • November 13th, 2007 • Vaxgen Inc • Pharmaceutical preparations • Delaware